Pure Global

Fibricheck Detection cApabilities for Atrial Fibrillation - Trial NCT06282380

Access comprehensive clinical trial information for NCT06282380 through Pure Global AI's free database. This phase not specified trial is sponsored by Qompium NV and is currently Not yet recruiting. The study focuses on Atrial Fibrillation. Target enrollment is 250 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06282380
Not yet recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT06282380
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Fibricheck Detection cApabilities for Atrial Fibrillation
Fibricheck Detection cApabilities for Atrial Fibrillation - a Multicenter Validation Study

Study Focus

Atrial Fibrillation

FibriCheck Mobile Application

Interventional

device

Sponsor & Location

Qompium NV

Timeline & Enrollment

N/A

Mar 01, 2024

May 01, 2024

250 participants

Primary Outcome

Accuracy of the FibriCheck Mobile Application

Summary

Evaluation of accuracy of the FibriCheck Mobile Application on various smartphone devices,
 compared to the reference diagnosis.

ICD-10 Classifications

Chronic atrial fibrillation
Persistent atrial fibrillation
Paroxysmal atrial fibrillation
Atrial fibrillation and flutter
Atrial fibrillation and atrial flutter, unspecified

Data Source

ClinicalTrials.gov

NCT06282380

Device Trial